• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Intraoperative Neurophysiological Monitoring Market Size

    ID: MRFR/MED/0258-CR
    114 Pages
    Rahul Gotadki
    August 2019

    Intraoperative Neurophysiological Monitoring Market Research Report Information By Surgical Procedure (Orthopedic, Urology, Spinal, Neurovascular, and Otolaryngology Surgery), By Type (Electroencephalography, Evoked Potentials, and Electromyography), By Methods (Outsourced, In-House, and Tele-Health), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast T...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Intraoperative Neurophysiological Monitoring Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Intraoperative Neurophysiological Monitoring Size

    Intraoperative Neurophysiological Monitoring Market Growth Projections and Opportunities

    The electroencephalography (EEG) segment emerged as the largest in the intraoperative neurophysiological monitoring market, recording a revenue of $670.1 million in 2015. It is projected to escalate to $1816.1 million by 2027, exhibiting a growth rate of 8.6% from 2016 to 2027. Simultaneously, electromyography (EMG) is identified as the fastest-growing segment, anticipated to experience a remarkable 9.3% compound annual growth rate (CAGR) during the forecast period.

    Within the type category, EEG dominated the market, securing the largest market share in 2015, generating $670.1 million in revenue. This segment is on a trajectory to reach $1816.1 million by 2027, reflecting an 8.6% CAGR. Conversely, EMG is emerging as the fastest-growing segment, poised for an impressive 9.3% CAGR over the forecasted period.

    Examining the intraoperative neurophysiological monitoring market by procedure, the spinal segment took the lead, accruing $748.4 million in revenue in 2015. Projections indicate an upswing to $2052.6 million by 2027, growing at a rate of 8.7% from 2016 to 2027. In tandem, orthopedic procedures are identified as the fastest-growing segment, expected to expand at a rate of 9.3% from 2016 to 2027.

    In terms of procedures, spinal interventions held the largest market share, amassing $748.4 million in revenue in 2015. Forecasts suggest a substantial increase to $2052.6 million by 2027, reflecting an 8.7% CAGR. Simultaneously, orthopedic procedures are identified as the fastest-growing segment, poised for a noteworthy 9.3% CAGR during the forecasted period.

    Segmenting the intraoperative neurophysiological monitoring market by method, the invasive segment exhibited dominance with a revenue of $687.5 million in 2015. Projections signal an upward trajectory, reaching $1862.7 million by 2027, growing at a rate of 8.6% from 2016 to 2027. In parallel, the non-invasive segment stands out as the fastest-growing, poised to expand at a rate of 9.3% from 2016 to 2027.

    Examining the market by method, the invasive approach garnered the largest market share, amassing $687.5 million in revenue in 2015. Forecasts predict a robust increase to $1862.7 million by 2027, reflecting an 8.6% CAGR. Simultaneously, the non-invasive method emerges as the fastest-growing segment, poised for a noteworthy 9.3% CAGR during the forecasted period.

    By source, the in-house segment led the intraoperative neurophysiological monitoring market, generating $670.4 million in revenue in 2015. Projections indicate an upward trajectory, reaching $1828.3 million by 2027, with a growth rate of 8.7% from 2016 to 2027. Meanwhile, the outsourced segment is identified as the fastest-growing, expected to expand at a rate of 9.2% from 2016 to 2027.

    Analyzing the market by source, the in-house segment exhibited dominance, securing the largest market share with $670.4 million in revenue in 2015. Forecasts suggest substantial growth to $1828.3 million by 2027, reflecting an 8.7% CAGR. Concurrently, the outsourced segment emerges as the fastest-growing, anticipated to expand at an impressive 9.2% CAGR during the forecasted period.

    Intraoperative Neurophysiological Monitoring Market Size Graph

    Market Summary

    As per Market Research Future Analysis, the Intraoperative Neurophysiological Monitoring Market was valued at 2.13 USD Billion in 2024 and is projected to grow to 5.46 USD Billion by 2035, with a CAGR of 8.92% from 2025 to 2035. The market is driven by the increasing demand for neuromonitoring technologies among surgeons and hospitals, alongside advancements in IONM technology. Key developments include FDA approvals for various monitoring systems and strategic acquisitions by major players to enhance their product portfolios.

    Key Market Trends & Highlights

    The market is witnessing significant growth due to technological advancements and increasing prevalence of neurological disorders.

    • Market Size in 2024: USD 2.13 Billion; Expected to reach USD 5.46 Billion by 2035.
    • CAGR from 2025 to 2035: 8.92%; driven by advancements in IONM technology.
    • North America accounted for USD 0.8244 Billion in 2022; expected to grow significantly due to favorable reimbursement policies.
    • Electromyography segment dominated the market in 2022; projected to be the fastest-growing segment during 2022-2030.

    Market Size & Forecast

    2024 Market Size USD 2.13 Billion
    2035 Market Size USD 5.46 Billion
    CAGR (2025-2035) 8.92%
    Largest Regional Market Share in 2022 North America.

    Major Players

    Key players include Cadwell Laboratories, IntraNerve, NeuroMonitoring Technologies, ProPep Surgical, Sentient Medical Systems, Accurate Monitoring LLC, Natus Medical Incorporated, NuVasive, Medsurant Holdings, Inomed Medizintechnik GmbH.

    Market Trends

    Growing Prevalence of spine degeneration to boost the market growth

    It has been a key part of manufacturers' product differentiation strategies to monitor the nervous system's health during spinal surgery. The need for neuromonitoring from surgeons and hospitals has grown over time due to advancements in IONM technology and techniques. This results from the manufacturer's proprietary software and ease of use. The ability of surgeons to make critical decisions in real-time thanks to intraoperative neuromonitoring devices makes operations safer, quicker, and more repeatable, which improves patient outcomes and is expected to drive growth.

    Additionally, developing cutting-edge tools like surgical robots, microscopes,ophthalmic surgical tools, and neurosurgery tools has reduced direct human interference in surgical procedures, which is also anticipated to support market growth in the near future. For example, the U.S. Food and Drug Administration granted 510(k) clearance to Medtronic plc in October 2020. S. To help lower the risk of nerve damage during head and neck surgeries, the FDA has approved the NIM Vital nerve monitoring system, which enables doctors to detect, monitor, and confirm nerve function.

    The NIM Vital system uses patented technology to deliver precise intraoperative nerve status data that affect surgical strategy and increase operative effectiveness. In the near future, growth is anticipated to be fueled by these factors.

    Additionally, developing cutting-edge tools like surgical robots, microscopes, ophthalmic surgical tools, and neurosurgery tools has reduced direct human interference in surgical procedures, which is also anticipated to support market growth in the near future. For instance, the U.S. FDA granted 510(k) clearance to Medtronic Plc in October 2020 in the U.S. To help lower the risk of nerve damage during head and neck surgeries, the FDA approved the NIM Vital nerve monitoring system, which enables doctors to detect, monitor, and confirm nerve function.

    The NIM Vital system uses patented technology to deliver accurate intraoperative nerve status information that affects surgical strategy and increases operative efficiency. In the near future, growth is anticipated to be fueled by these factors, which has enhanced the Intraoperative Neurophysiological Monitoring market CAGR globally in recent years.

    The increasing complexity of surgical procedures necessitates the integration of advanced neurophysiological monitoring techniques to enhance patient safety and surgical outcomes.

    U.S. National Institutes of Health

    Intraoperative Neurophysiological Monitoring Market Market Drivers

    Market Growth Projections

    Regulatory Support and Guidelines

    Regulatory bodies are increasingly recognizing the importance of intraoperative neurophysiological monitoring, leading to the establishment of supportive guidelines that promote its use in surgical settings. This regulatory support is crucial for the Global Intraoperative Neurophysiological Monitoring Market Industry, as it encourages healthcare facilities to adopt these monitoring techniques. Enhanced regulations ensure that monitoring practices meet safety and efficacy standards, thereby boosting confidence among healthcare providers. As a result, the market is poised for growth, with the potential for increased investments in monitoring technologies and training programs for surgical teams.

    Rising Demand for Surgical Procedures

    The Global Intraoperative Neurophysiological Monitoring Market Industry experiences a notable surge in demand due to the increasing number of surgical procedures performed worldwide. As healthcare systems evolve, the integration of advanced monitoring techniques becomes essential for ensuring patient safety and optimal surgical outcomes. For instance, the market is projected to reach 2.13 USD Billion in 2024, reflecting a growing recognition of the importance of intraoperative neurophysiological monitoring in complex surgeries. This trend is likely to continue, driven by advancements in surgical technologies and an increasing focus on minimizing neurological complications during operations.

    Expansion of Healthcare Infrastructure

    The expansion of healthcare infrastructure, particularly in emerging economies, is a significant driver for the Global Intraoperative Neurophysiological Monitoring Market Industry. As hospitals and surgical centers upgrade their facilities and invest in advanced technologies, the demand for intraoperative monitoring solutions is likely to rise. This trend is particularly evident in regions where access to quality surgical care is improving, leading to a greater emphasis on patient safety and outcomes. The ongoing development of healthcare infrastructure suggests a robust future for the market, as more facilities integrate neurophysiological monitoring into their surgical protocols.

    Technological Advancements in Monitoring Equipment

    Technological innovations play a pivotal role in shaping the Global Intraoperative Neurophysiological Monitoring Market Industry. The development of sophisticated monitoring devices, such as portable and real-time neurophysiological monitoring systems, enhances the accuracy and reliability of intraoperative assessments. These advancements not only improve surgical outcomes but also facilitate quicker recovery times for patients. As a result, the market is expected to grow significantly, with projections indicating a rise to 5.47 USD Billion by 2035. The continuous evolution of technology in this field suggests a promising future for both healthcare providers and patients.

    Increasing Awareness of Neurophysiological Monitoring Benefits

    There is a growing awareness among healthcare professionals and patients regarding the benefits of intraoperative neurophysiological monitoring, which is significantly influencing the Global Intraoperative Neurophysiological Monitoring Market Industry. This awareness is driven by educational initiatives and clinical evidence demonstrating the effectiveness of monitoring techniques in reducing postoperative complications. As more surgeons adopt these practices, the market is likely to expand, supported by a projected compound annual growth rate of 8.95% from 2025 to 2035. This trend indicates a shift towards more proactive approaches in surgical care, emphasizing the importance of real-time monitoring.

    Market Segment Insights

    Intraoperative Neurophysiological Monitoring Surgical Procedure Insights

    Based on Surgical Procedure, the Intraoperative Neurophysiological Monitoring Market segmentation includes Orthopedic, Urology, Spinal, Neurovascular, and Otolaryngology Surgery. The Spinal segment held the majority share in 2022 contribution concerning the Intraoperative Neurophysiological Monitoring Market revenue. It can also evaluate the spinal cord and nerve roots after surgery to ensure proper cervical spine positioning. Its use in cervical spine surgery is wider than monitoring sensory tracts during the procedure. But SSEP changes during surgery are not always linked to postoperative neurological deficits because of its allegedly low specificity34, according to 33–35 studies.

    As a result, many researchers advise against using it as the sole monitoring modality in difficult cervical procedures.

    Intraoperative Neurophysiological Monitoring Type Insights

    The Intraoperative Neurophysiological Monitoring Market segmentation, based on type, includes Electroencephalography, Evoked Potentials, and Electromyography. The Electromyography segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The motor neurons that control muscles and the muscles are evaluated using a diagnostic procedure called electromyography (EMG). According to EMG results, there may be issues with nerve-to-muscle signal transmission, muscle dysfunction, or both positively impact the market growth.

    Intraoperative Neurophysiological Monitoring Methods Insights

    The Intraoperative Neurophysiological Monitoring Market data has been bifurcated by surgery into Outsourced, In-House, and Tele-Health. The Outsourced segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Hospitals and healthcare facilities outsource their IONM needs due to cost-effectiveness and the availability of specialized service providers. IONM technology is constantly evolving and changing. Hospitals are relieved of the cost of purchasing and maintaining this equipment thanks to outsourcing. Additionally, training neurophysiologists is costly and time-consuming.

    Figure 1: Intraoperative Neurophysiological Monitoring Market, by Methods, 2022 & 2030 (USD Billion)

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Get more detailed insights about Intraoperative Neurophysiological Monitoring Market Research Report - Global Forecast to 2034

    Regional Insights

    By Region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North America Intraoperative Neurophysiological Monitoring market accounted for USD 0.8244 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. According to the U.S. National Institute of Health, this dominance is largely due to the favorable reimbursement environment and rising neurological disorder cases. Around 795,000 people have a stroke annually, which results in 137,000 fatalities. Additionally, the Migraine Research Foundation estimates that in 2020, about 35 million U.S. people will experience migraine headaches.

    Additionally, it is anticipated that 18% of men and 43% of women will suffer from migraines nationwide.

    Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2: INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET SHARE BY REGION 2022 (%)INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET SHARE BY REGION 2022

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Europe’s Intraoperative Neurophysiological Monitoring market accounts for the second-largest market share. Approximately 35 million people in the United States experience migraine headaches, according to statistics from the Migraine Research Foundation that were updated in 2021. Additionally, it is anticipated that 18% of men and 43% of women will suffer from migraines nationwide. Therefore, it is likely that the rise in neurological disorders like TBI, migraine, and stroke will propel market expansion in this nation.

    Further, the Germany Intraoperative Neurophysiological Monitoring market held the largest market share, and the UK Intraoperative Neurophysiological Monitoring market was the fastest-growing market in the European region.

    The Asia-Pacific Intraoperative Neurophysiological Monitoring Market is expected to grow at the fastest CAGR from 2022 to 2030. Over the forecast period, emerging economies like China, Japan, South Korea, and India will experience significant growth. In China and Japan, numerous local players may foster market expansion. Additionally, it is anticipated that the local market will be driven in the upcoming years by the growing geriatric population and the incidence of traumatic brain injuries. For example, the national 2020 census estimates that about 264 million (18.7%) Chinese are 60 or older.

    Moreover, China’s Intraoperative Neurophysiological Monitoring market held the largest market share, and India’s Intraoperative Neurophysiological Monitoring market was the fastest-growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Major market players are spending much money on R&D to increase their product lines, which will help the Intraoperative Neurophysiological Monitoring market grow even more. Market participants are also taking various strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Intraoperative Neurophysiological Monitoring industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

    One of the primary business strategies manufacturers adopt in the Global Intraoperative Neurophysiological Monitoring industry to benefit clients and expand the market sector is manufacturing locally to reduce operating costs. In recent years, the Intraoperative Neurophysiological Monitoring industry has provided medicine with some of the most significant benefits.

    In the Intraoperative Neurophysiological Monitoring market, major players such as Cadwell Laboratories (US), IntraNerve (US), NeuroMonitoring Technologies (US), ProPep Surgical (US),  Sentient Medical Systems (US), Accurate Monitoring LLC (US), Natus Medical Incorporated (US), NuVasive (US), Medsurant Holdings (US), Inomed Medizintechnik GmbH (Germany) and others are working on expanding the market demand by investing in research and development activities.

    Cadwell Laboratories (US): During his residency at the University of Washington School of Medicine, John Cadwell, MD, BSEE, created the first microprocessor EMG in his Seattle home's basement. He co-founds Cadwell Laboratories with his brother, Carl Cadwell, DDS. The Cadwell 7000 EMG is their initial offering. Putting Cadwell on the map is the 5200A. This machine, which is compact, strong, reliable, and simple to use, has become the most popular EMG device ever produced. The business has outgrown its previous location and relocated to 909 N. Street Kellogg in 1986.

    The next generation of ApneaTrak HSAT is introduced with completely disposable patient kits to assist sleep laboratories in providing secure home testing options. Serving new markets and enhancing its offerings, Cadwell keeps growing. The business stays true to its purpose: assisting you in aiding others.

    Also, IntraNerve (US) is a planned rollout that identifies development-related issues that have been extremely beneficial. I saw [INN] gently guiding individuals in my organization toward contracting and credentialing. The services provided by [INN] will enhance patient care, and we directly benefit from them. We are a full-service tertiary care facility, so if we didn't have the option of working with [INN], we could create our expertise.

    Key Companies in the Intraoperative Neurophysiological Monitoring Market market include

    Industry Developments

    INVASIVE INC. announced the official opening of its Singapore Experience Center for the Asia-Pacific region, supporting its growth strategy to expand its business internationally.

    March 2021

    The V4 4-channel and 8-channel nerve monitoring systems from Neurosign have received approval from the US Food and Drug Administration, and they are currently being used on patients in the US for nerve identification and preservation.

    Future Outlook

    Intraoperative Neurophysiological Monitoring Market Future Outlook

    The Intraoperative Neurophysiological Monitoring Market is projected to grow at 8.92% CAGR from 2025 to 2035, driven by technological advancements, increasing surgical procedures, and heightened patient safety awareness.

    New opportunities lie in:

    • Develop AI-driven monitoring systems to enhance real-time data analysis and decision-making.
    • Expand service offerings to include remote monitoring solutions for post-operative care.
    • Invest in training programs for surgical teams to optimize the use of neurophysiological monitoring technologies.

    By 2035, the market is expected to exhibit robust growth, positioning itself as a critical component of surgical safety.

    Market Segmentation

    Intraoperative Neurophysiological Monitoring Type Outlook

    • Electroencephalography
    • Evoked Potentials
    • Electromyography

    Intraoperative Neurophysiological Monitoring Methods Outlook

    • Outsourced
    • In-House
    • Tele-Health

    Intraoperative Neurophysiological Monitoring Regional Outlook

    North America
    • US
    • Canada

    Intraoperative Neurophysiological Monitoring Surgical Procedure Outlook

    • Orthopedic
    • Urology
    • Spinal
    • Neurovascular
    • Otolaryngology Surgery

    Report Scope

    Attribute/Metric Details
    Market Size 2024    2.13 (USD Billion)
    Market Size 2025    2.33 (USD Billion)
    Market Size 2035 5.46 (USD Billion)
    Compound Annual Growth Rate (CAGR) 8.92% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Surgical Procedure, Type, Methods and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Cadwell Laboratories (US), IntraNerve (US),  NeuroMonitoring Technologies (US), ProPep Surgical (US),  Sentient Medical Systems (US), Accurate Monitoring LLC (US), Natus Medical Incorporated (US), NuVasive (US), Medsurant Holdings (US), Inomed Medizintechnik GmbH (Germany)
    Key Market Opportunities Development of cutting-edge tools like surgical robots
    Key Market Dynamics Rising world population and average life expectancy.

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is the projected growth of the Intraoperative Neurophysiological Monitoring market?

    The Intraoperative Neurophysiological Monitoring market is the expected increase in total market value of 5.46 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Intraoperative Neurophysiological Monitoring market?

    Intraoperative Neurophysiological Monitoring market size was valued at approximately 2.13 billion USD in 2024. This figure will reach 5.46 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Intraoperative Neurophysiological Monitoring market?

    Intraoperative Neurophysiological Monitoring market is expected to grow at a CAGR of 8.92% between 2025 and 2035.

    How much will the Intraoperative Neurophysiological Monitoring market be worth by 2035?

    Intraoperative Neurophysiological Monitoring market is expected to be worth of 5.46 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Intraoperative Neurophysiological Monitoring market perform over the next 10 years?

    Over the next 10 years the Intraoperative Neurophysiological Monitoring market is expected to shift from usd billion 2.13 to 5.46 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region held the largest market share in the Intraoperative Neurophysiological Monitoring market?

    North America had the largest share of the Global market

    1. List of Tables and Figures
      1.  
      2. TABLE 1 GLOBAL INTRAOPERATIVE
      3. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 21
      4.  
      5. TABLE
      6. 2 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET: ELECTROENCEPHALOGRAPHY,
      7. BY REGION, 2023–2030 (USD MILLION) 22
      8.  
      9. TABLE
      10. 3 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET: ELECTROMYOGRAPHY,
      11. BY REGION, 2023–2030 (USD MILLION) 23
      12.  
      13. TABLE
      14. 4 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET: EVOKED POTENTIALS,
      15. BY REGION, 2023–2030 (USD MILLION) 24
      16.  
      17. TABLE
      18. 5 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      19. (USD MILLION) 26
      20.  
      21. TABLE 6 GLOBAL INTRAOPERATIVE
      22. NEUROPHYSIOLOGICAL MONITORING MARKET: SPINAL, BY REGION, 2023–2030 (USD MILLION)
      23. 27
      24.  
      25. TABLE 7 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL
      26. MONITORING MARKET: NEUROVASCULAR, BY REGION, 2023–2030 (USD MILLION) 28
      27.  
      28. TABLE
      29. 11 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      30. (USD MILLION) 33
      31.  
      32. TABLE 12 GLOBAL INTRAOPERATIVE
      33. NEUROPHYSIOLOGICAL MONITORING MARKET, INVASIVE, 2023–2030 (USD MILLION) 34
      34.  
      35. TABLE
      36. 13 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, NON INVASIVE, 2023–2030
      37. (USD MILLION) 35
      38.  
      39. TABLE 14 GLOBAL INTRAOPERATIVE
      40. NEUROPHYSIOLOGICAL MONITORING MARKET, MINIMALLY INVASIVE, 2023–2030 (USD MILLION)
      41. 35
      42.  
      43. TABLE 15 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL
      44. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 38
      45.  
      46. TABLE
      47. 16 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, IN-HOUSE, 2023–2030
      48. (USD MILLION) 39
      49.  
      50. TABLE 17 GLOBAL INTRAOPERATIVE
      51. NEUROPHYSIOLOGICAL MONITORING MARKET, OUTSOURCED, 2023–2030 (USD MILLION)
      52. 40
      53.  
      54. TABLE 18 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL
      55. MONITORING MARKET, TELE-HEALTH, 2023–2030 (USD MILLION) 41
      56.  
      57. TABLE
      58. 19 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY REGION, 2023–2030
      59. (USD MILLION) 42
      60.  
      61. TABLE 20 NORTH AMERICA INTRAOPERATIVE
      62. NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY (%) 43
      63.  
      64. TABLE
      65. 21 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY,
      66. 2023–2030 (USD MILLION) 44
      67.  
      68. TABLE 22 NORTH
      69. AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 44
      70.  
      71. TABLE
      72. 23 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      73. (USD MILLION) 45
      74.  
      75. TABLE 24 NORTH AMERICA INTRAOPERATIVE
      76. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      77. 46
      78.  
      79. TABLE 25 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL
      80. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 47
      81.  
      82. TABLE
      83. 26 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE,
      84. 2023–2030 (USD MILLION) 48
      85.  
      86. TABLE 27 US
      87. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD
      88. MILLION) 48
      89.  
      90. TABLE 28 US INTRAOPERATIVE NEUROPHYSIOLOGICAL
      91. MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 49
      92.  
      93. TABLE
      94. 29 US INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      95. (USD MILLION) 49
      96.  
      97. TABLE 30 US INTRAOPERATIVE NEUROPHYSIOLOGICAL
      98. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 50
      99.  
      100. TABLE
      101. 31 CANADA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      102. (USD MILLION) 50
      103.  
      104. TABLE 32 CANADA INTRAOPERATIVE
      105. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      106. 51
      107.  
      108. TABLE 33 CANADA INTRAOPERATIVE NEUROPHYSIOLOGICAL
      109. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 51
      110.  
      111. TABLE
      112. 34 CANADA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      113. (USD MILLION) 52
      114.  
      115. TABLE 35 EUROPE INTRAOPERATIVE
      116. NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
      117. 54
      118.  
      119. TABLE 36 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL
      120. MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 55
      121.  
      122. TABLE
      123. 37 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      124. (USD MILLION) 56
      125.  
      126. TABLE 38 EUROPE INTRAOPERATIVE
      127. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION)
      128. 57
      129.  
      130. TABLE 39 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL
      131. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 58
      132.  
      133. TABLE
      134. 40 GERMANY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      135. (USD MILLION) 59
      136.  
      137. TABLE 41 GERMANY INTRAOPERATIVE
      138. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      139. 59
      140.  
      141. TABLE 42 GERMANY INTRAOPERATIVE NEUROPHYSIOLOGICAL
      142. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 60
      143.  
      144. TABLE
      145. 43 GERMANY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      146. (USD MILLION) 60
      147.  
      148. TABLE 44 FRANCE INTRAOPERATIVE
      149. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 61
      150.  
      151. TABLE
      152. 45 FRANCE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      153. (USD MILLION) 61
      154.  
      155. TABLE 46 FRANCE INTRAOPERATIVE
      156. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION)
      157. 62
      158.  
      159. TABLE 47 FRANCE INTRAOPERATIVE NEUROPHYSIOLOGICAL
      160. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 62
      161.  
      162. TABLE
      163. 48 UK INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      164. (USD MILLION) 63
      165.  
      166. TABLE 49 UK INTRAOPERATIVE NEUROPHYSIOLOGICAL
      167. MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 63
      168.  
      169. TABLE
      170. 50 UK INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      171. (USD MILLION) 64
      172.  
      173. TABLE 51 UK INTRAOPERATIVE NEUROPHYSIOLOGICAL
      174. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 64
      175.  
      176. TABLE
      177. 52 ITALY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      178. (USD MILLION) 65
      179.  
      180. TABLE 53 ITALY INTRAOPERATIVE
      181. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      182. 65
      183.  
      184. TABLE 54 ITALY INTRAOPERATIVE NEUROPHYSIOLOGICAL
      185. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 66
      186.  
      187. TABLE
      188. 55 ITALY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      189. (USD MILLION) 66
      190.  
      191. TABLE 56 SPAIN INTRAOPERATIVE
      192. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 67
      193.  
      194. TABLE
      195. 57 SPAIN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      196. (USD MILLION) 67
      197.  
      198. TABLE 58 SPAIN INTRAOPERATIVE
      199. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION)
      200. 68
      201.  
      202. TABLE 59 SPAIN INTRAOPERATIVE NEUROPHYSIOLOGICAL
      203. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 68
      204.  
      205. TABLE
      206. 60 EASTERN EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE,
      207. 2023–2030 (USD MILLION) 69
      208.  
      209. TABLE 61 EASTERN
      210. EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      211. (USD MILLION) 69
      212.  
      213. TABLE 62 EASTERN EUROPE INTRAOPERATIVE
      214. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION)
      215. 70
      216.  
      217. TABLE 63 EASTERN EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL
      218. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 70
      219.  
      220. TABLE
      221. 64 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY,
      222. 2023–2030 (USD MILLION) 71
      223.  
      224. TABLE 65 ASIA-PACIFIC
      225. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD
      226. MILLION) 72
      227.  
      228. TABLE 66 ASIA-PACIFIC INTRAOPERATIVE
      229. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      230. 73
      231.  
      232. TABLE 67 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL
      233. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 74
      234.  
      235. TABLE
      236. 68 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE,
      237. 2023–2030 (USD MILLION) 75
      238.  
      239. TABLE 69 JAPAN
      240. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD
      241. MILLION) 76
      242.  
      243. TABLE 70 JAPAN INTRAOPERATIVE NEUROPHYSIOLOGICAL
      244. MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 76
      245.  
      246. TABLE
      247. 71 JAPAN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      248. (USD MILLION) 77
      249.  
      250. TABLE 72 JAPAN INTRAOPERATIVE
      251. NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 77
      252.  
      253. TABLE
      254. 73 CHINA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      255. (USD MILLION) 78
      256.  
      257. TABLE 74 CHINA INTRAOPERATIVE
      258. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      259. 78
      260.  
      261. TABLE 75 CHINA INTRAOPERATIVE NEUROPHYSIOLOGICAL
      262. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 79
      263.  
      264. TABLE
      265. 76 CHINA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      266. (USD MILLION) 79
      267.  
      268. TABLE 77 INDIA INTRAOPERATIVE
      269. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 80
      270.  
      271. TABLE
      272. 78 INDIA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      273. (USD MILLION) 80
      274.  
      275. TABLE 79 INDIA INTRAOPERATIVE
      276. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION)
      277. 81
      278.  
      279. TABLE 80 INDIA INTRAOPERATIVE NEUROPHYSIOLOGICAL
      280. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 81
      281.  
      282. TABLE
      283. 81 SOUTH KOREA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023-
      284. 2030 (USD MILLION) 82
      285.  
      286. TABLE 82 SOUTH KOREA INTRAOPERATIVE
      287. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      288. 82
      289.  
      290. TABLE 83 SOUTH KOREA INTRAOPERATIVE NEUROPHYSIOLOGICAL
      291. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 83
      292.  
      293. TABLE
      294. 84 SOUTH KOREA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      295. (USD MILLION) 83
      296.  
      297. TABLE 85 MIDDLE EAST & AFRICA
      298. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY REGION, 2023–2030
      299. (USD MILLION) 84
      300.  
      301. TABLE 86 MIDDLE EAST & AFRICA
      302. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD
      303. MILLION) 85
      304.  
      305. TABLE 87 MIDDLE EAST & AFRICA
      306. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      307. (USD MILLION) 86
      308.  
      309. TABLE 88 MIDDLE EAST & AFRICA
      310. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      311. (USD MILLION) 87
      312.  
      313. TABLE 89 MIDDLE EAST & AFRICA
      314. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      315. (USD MILLION) 88
      316.  
      317. TABLE 90 MIDDLE EAST INTRAOPERATIVE
      318. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 89
      319.  
      320. TABLE
      321. 91 MIDDLE EAST INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE,
      322. 2023–2030 (USD MILLION) 89
      323.  
      324. TABLE 92 MIDDLE
      325. EAST INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      326. (USD MILLION) 90
      327.  
      328. TABLE 93 MIDDLE EAST INTRAOPERATIVE
      329. NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 90
      330.  
      331. TABLE
      332. 94 AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      333. (USD MILLION) 91
      334.  
      335. TABLE 95 AFRICA INTRAOPERATIVE
      336. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      337. 91
      338.  
      339. TABLE 96 AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL
      340. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 92
      341.  
      342. TABLE
      343. 97 AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      344. (USD MILLION) 92
      345.  
    2. List of Tables and Figures
      1.  
      2. FIGURE
      3. 1 RESEARCH PROCESS 15
      4.  
      5. FIGURE 2 GLOBAL INTRAOPERATIVE
      6. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 21
      7.  
      8. FIGURE
      9. 3 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE 26
      10.  
      11. FIGURE
      12. 4 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS 33
      13.  
      14. FIGURE
      15. 5 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 38
      16.  
      17. FIGURE
      18. 6 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY REGION 42
      19.  
      20. FIGURE
      21. 7 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE
      22. 45
      23.  
      24. FIGURE 8 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL
      25. MONITORING MARKET, BY METHODS 46
      26.  
      27. FIGURE 9 NORTH
      28. AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 47
      29.  
      30. FIGURE
      31. 10 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY (%) 53
      32.  
      33. FIGURE
      34. 11 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 55
      35.  
      36. FIGURE
      37. 12 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE 56
      38.  
      39. FIGURE
      40. 13 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS 57
      41.  
      42. FIGURE
      43. 14 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 58
      44.  
      45. FIGURE
      46. 15 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY
      47. (%) 71
      48.  
      49. FIGURE 16 ASIA-PACIFIC INTRAOPERATIVE
      50. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 72
      51.  
      52. FIGURE
      53. 17 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE
      54. 73
      55.  
      56. FIGURE 18 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL
      57. MONITORING MARKET, BY METHODS 74
      58.  
      59. FIGURE 19 ASIA-PACIFIC
      60. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 75
      61.  
      62. FIGURE
      63. 20 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET,
      64. BY REGION (%) 84
      65.  
      66. FIGURE 21 MIDDLE EAST &
      67. AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 85
      68.  
      69. FIGURE
      70. 22 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET,
      71. BY PROCEDURE 86
      72.  
      73. FIGURE 23 MIDDLE EAST & AFRICA
      74. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS 87
      75.  
      76. FIGURE
      77. 24 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET,
      78. BY SOURCE 88

    Intraoperative Neurophysiological Monitoring Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials